登录

ForceClouds Raises $10 Million Series B Funding, Providing Sales and R&D Management for Medical Company with Cloud Solution

作者: Mailman 2019-12-02 19:49
云势软件
http://www.forceclouds.com/
企业数据由 动脉橙 提供支持
医药行业SaaS服务提供商 | 战略融资 | 运营中
中国-北京
2021-06-04
腾讯投资
查看

According to 36Kr.com, ForceClouds, a cloud solution provider targeting the field of life sciences, has completed a $10 million Series B financing, led by Eight Roads, with participation from Anshun Fuhai High-Tech Venture Capital and Blue Lake Capital. Hu Junping, President of ForceClouds, said the proceeds of this financing would mainly be used for product research and development.


ForceClouds is specialized in using cloud computing, big data and artificial intelligence technology to provide cloud solutions of information management for pharmaceutical, CRO, medical equipment, animal health, crop science, nutrition and healthcare companies, hospitals and so on. At present, ForceClouds has cooperated with nearly 100 enterprises, including AstraZeneca, Bayer, MSD, ThermoFisher, B. Braun, bioMerieux and other large multinational pharmaceutical enterprises, as well as Hengrui Medical, Hansoh Pharma, and other Chinese leading enterprises.


Focusing on the three aspects including marketing, clinical trial and new drug research and development of pharmaceutical enterprises, ForceClouds has developed three kinds of products, respectively for sales management, clinical trial, and big data with artificial intelligence.


SFEpower, the one-stop sales efficiency management platform of ForceClouds,  helps pharmaceutical enterprises improve the efficiency of sales management in marketing and commercialization, to catch the need of customers more effectively and accurately. VirgoClinical, a software for drug discovery and clinical trial management, provides systematic services of clinical trials to pharmaceutical companies, hospitals, and CRO companies, helping them ensure compliance with clinical trial data management standards, improve the quality of data and help companies reduce development costs. In general, ForceClouds, which started with sales management, has been gradually transformed into a provider of whole-process solutions covering pharmaceutical research and development, clinical trials, and sales.


>>>>

About Eight Roads


Eight Roads is committed to supporting entrepreneurs as they scale their businesses. The company not only invests in businesses through its own funds, but also makes direct investments and identify themes and talented teams to start businesses from scratch. In the past 10 years alone, Eight Roads has invested almost $6 billion into growing companies in technology and healthcare.


>>>>

About Blue Lake Capital


As a next-generation, research-driven venture capital firm, Blue Lake Capital primarily invests in emerging industries that are transforming from traditional industry models to upgraded, high-tech innovative model. The company focuses on early-stage start-ups in the following sectors; enterprise software and service, consumer internet and smart manufacturing.


Blue Lake Capital manages funds denominated in USD and RMB. Leveraging its network of successful entrepreneurs and its extensive experience, Blue Lake Capital supports the growth of companies into market leaders.

相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

Taimei Technology Completes 1.5 Billion Yuan Series E financing

谷歌风投、OrbiMed等多家顶级投资机构,他们在海外投什么医疗企业

Oceanus Plus Snares ¥10M in Series A+ Round

Nanyan Insurtech Completes ¥100M Series B2 Funding

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

15条措施、7个实施节点,药品集采和使用品种范围已明确将扩大

2019-12-02
下一篇

峻山生物:聚焦病理科整体解决方案和癌症早筛,公司迈入高速发展期

2019-12-03